Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ethinylestradiol manufacturers

7 products found

Filters

Filters

Filters , active

Country of origin : Egypt

Clear all

7 products found

ethinylestradiol + drospirenone

Tablets, film coated 0.03 mg + 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
WHO
Manufacturer #274
This pharmaceutical company, established over three decades ago, boasts a strong presence across numerous regions, including the Middle East and Africa. The company's portfolio encompasses a wide range of products, including prescription and over-the-counter medications, as well as food supplements. Their manufacturing facilities adhere to stringent quality standards, boasting EU and US GMP certifications. The company is known for its dedication to research and development, reflected in its numerous product patents. Their key therapeutic areas include infectious diseases, cardiovascular health, and anti-viral therapies. This commitment to innovation has resulted in a significant impact on patient care, particularly in the field of hepatitis C treatment.

Manufacturer usually replies in 1 days

ethinylestradiol + gestodene

Tablets, film coated 0.05 mg + 0.075 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
WHO
Manufacturer #274
This pharmaceutical company, established over three decades ago, boasts a strong presence across numerous regions, including the Middle East and Africa. The company's portfolio encompasses a wide range of products, including prescription and over-the-counter medications, as well as food supplements. Their manufacturing facilities adhere to stringent quality standards, boasting EU and US GMP certifications. The company is known for its dedication to research and development, reflected in its numerous product patents. Their key therapeutic areas include infectious diseases, cardiovascular health, and anti-viral therapies. This commitment to innovation has resulted in a significant impact on patient care, particularly in the field of hepatitis C treatment.

Manufacturer usually replies in 1 days

norgestimate + ethinylestradiol

Tablets, film coated 0.025 mg + 0.035 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
WHO
Manufacturer #274
This pharmaceutical company, established over three decades ago, boasts a strong presence across numerous regions, including the Middle East and Africa. The company's portfolio encompasses a wide range of products, including prescription and over-the-counter medications, as well as food supplements. Their manufacturing facilities adhere to stringent quality standards, boasting EU and US GMP certifications. The company is known for its dedication to research and development, reflected in its numerous product patents. Their key therapeutic areas include infectious diseases, cardiovascular health, and anti-viral therapies. This commitment to innovation has resulted in a significant impact on patient care, particularly in the field of hepatitis C treatment.

Manufacturer usually replies in 1 days

Want to see all 7 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Ethinylestradiol Uses

Ethinylestradiol is an estrogen medication that widely used in birth control pills in combination with Progestins. In the past, Ethinylestradiol was earlier prescribed to treat various indications such as menopausal symptoms, gynecological disorders, and certain hormone-sensitive cancers. Ethinylestradiol is agonist of the estrogen receptors, the biological target of estrogens like estradiol. It is a synthetic derivative of estradiol, a natural estrogen but differs from it in various ways. Compared to estradiol, Ethinylestradiol has greatly improved bioavailability when taken by mouth, in addition to being more resistant to metabolism. It also shows relatively better efficacy in certain parts of the body like the liver and uterus. These differences make Ethinylestradiol more favorable for use in birth control pills than estradiol. However, high usage can Increase the risk of blood clots and certain other rare adverse side effects.
Ethinylestradiol was the first orally active synthetic estrogen and was described in 1938 by Hans Herloff Inhoffen and Walter Hohlweg of Schering AG in Berlin. Schering got the first approval from the FDA in 1943. It is marketed under the brand name Estinyl. However, it only started being used as birth control pills later in the 1960s. Today, Ethinylestradiol is the exclusive estrogen used for this purpose, making it one of if not the most widely used estrogens. The FDA withdrew approval of Estinyl effective in 2004 at the request of Schering, which had discontinued marketing it. However, the given the obvious societal benefits of the medicine, It is manufactured and sold under several brand names by global and local manufacturers and labelers.

Forms and Dosage

Ethinylestradiol was previously available by itself under the brand name Estinyl in the form of 0.02, 0.05, and 0.5 mg (20, 50, and 500 µg) tablets. It is usually taken by mouth but is also used as a patch and vaginal ring. Ethinylestradiol is available in combination with a progestin as a transdermal contraceptive patch and as a contraceptive vaginal ring. In addition, there is a single preparation containing very low doses of Ethinylestradiol plus a progestin in an oral tablet that remains in use for menopausal hormone therapy.

The cost of Ethinylestradiol

For bulk industrial usage, the powder form is sold commercially at about USD 500. However, one of the commonly sold brands sells for about USD 100 for monthly supply of 30 tablets. In developing world, the price of imported powder is can vary between USD 15-30 due to domestic manufacturers.

How does Ethinylestradiol work?

Ethinylestradiol is a synthetic estrogenic compound. Use of estrogens have a number of effects on the body including reduced bone density. Combined oral contraceptives suppress ovulation by thickening the cervical mucus to prevent sperm from traveling, and preventing changes in the endometrium required in the implantation of a fertilized egg.

Finding Ethinylestradiol Manufacturers and Ethinylestradiol Suppliers

One of the fastest and easiest ways to find Ethinylestradiol manufacturers and Ethinylestradiol suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals.
Usually, finding trusted manufacturers and supplies of specific drugs like Ethinylestradiol can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier.
All you need to do to get started is make use of our integrated search engine and start looking for suppliers or manufacturers of Ethinylestradiol to work with. You can fine-tune your search results using various filters too, letting you search for Ethinylestradiol from specific countries.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible